SPTBN2 and ovarian carcinoma: In recent studies, it has been confirmed that the mRNA and protein levels of SPTBN2 were upregulated in ovarian cancer, and which was involved in a variety of biological processes associated with tumorigenesis and was highly associated with poor prognosis of ovarian cancer [9].